Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.
Identifieur interne : 000138 ( Main/Exploration ); précédent : 000137; suivant : 000139Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.
Auteurs : Joan Puig-Barberà [Espagne] ; Elena Burtseva [Russie] ; Hongjie Yu [République populaire de Chine] ; Benjamin J. Cowling [République populaire de Chine] ; Selim Badur [Turquie] ; Jan Kyncl [République tchèque] ; Anna Sominina [Russie]Source :
- BMC public health [ 1471-2458 ] ; 2016.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Brésil (épidémiologie), Chine (épidémiologie), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Hospitalisation (MeSH), Humains (MeSH), Mâle (MeSH), Nourrisson (MeSH), Nouveau-né (MeSH), Russie (épidémiologie), République tchèque (épidémiologie), Saisons (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Surveillance de la population (MeSH), Turquie (épidémiologie), Vaccins antigrippaux (immunologie), Études prospectives (MeSH).
- MESH :
- immunologie : Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- épidémiologie : Brésil, Chine, Espagne, Grippe humaine, Russie, République tchèque, Turquie.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Femelle, Hospitalisation, Humains, Mâle, Nourrisson, Nouveau-né, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance de la population, Études prospectives.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Brazil (epidemiology), Child (MeSH), Child, Preschool (MeSH), China (epidemiology), Czech Republic (epidemiology), Female (MeSH), Hospitalization (MeSH), Humans (MeSH), Infant (MeSH), Infant, Newborn (MeSH), Influenza Vaccines (immunology), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), Population Surveillance (MeSH), Prospective Studies (MeSH), Russia (epidemiology), Seasons (MeSH), Spain (epidemiology), Turkey (epidemiology).
- MESH :
- chemical , immunology : Influenza Vaccines.
- epidemiology : Brazil, China, Czech Republic, Influenza, Human, Russia, Spain, Turkey.
- prevention & control : Influenza, Human.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Hospitalization, Humans, Infant, Infant, Newborn, Male, Middle Aged, Population Surveillance, Prospective Studies, Seasons.
Abstract
The Global Influenza Hospital Surveillance Network (GIHSN) has established a prospective, active surveillance, hospital-based epidemiological study to collect epidemiological and virological data for the Northern and Southern Hemispheres over several consecutive seasons. It focuses exclusively on severe cases of influenza requiring hospitalization. A standard protocol is shared between sites allowing comparison and pooling of results. During the 2014-2015 influenza season, the GIHSN included seven coordinating sites from six countries (St. Petersburg and Moscow, Russian Federation; Prague, Czech Republic; Istanbul, Turkey; Beijing, China; Valencia, Spain; and Rio de Janeiro, Brazil). Here, we present the detailed epidemiological and influenza vaccine effectiveness findings for the Northern Hemisphere 2014-2015 influenza season.
DOI: 10.1186/s12889-016-3378-1
PubMed: 27556802
PubMed Central: PMC5001209
Affiliations:
- Espagne, Russie, République populaire de Chine, République tchèque, Turquie
- Bohême centrale
- Prague, Pékin
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.</title>
<author><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<affiliation wicri:level="1"><nlm:affiliation>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia, Spain. puig_joa@gva.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name>
<affiliation wicri:level="1"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region</wicri:regionArea>
<wicri:noRegion>Special Administrative Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name>
<affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kyncl, Jan" sort="Kyncl, Jan" uniqKey="Kyncl J" first="Jan" last="Kyncl">Jan Kyncl</name>
<affiliation wicri:level="3"><nlm:affiliation>National Institute of Public Health (NIPH), Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>National Institute of Public Health (NIPH), Prague</wicri:regionArea>
<placeName><settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name>
<affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, Saint Petersburg, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>Research Institute of Influenza, Saint Petersburg, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27556802</idno>
<idno type="pmid">27556802</idno>
<idno type="doi">10.1186/s12889-016-3378-1</idno>
<idno type="pmc">PMC5001209</idno>
<idno type="wicri:Area/Main/Corpus">00122</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00122</idno>
<idno type="wicri:Area/Main/Curation">000122</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000122</idno>
<idno type="wicri:Area/Main/Exploration">000122</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.</title>
<author><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<affiliation wicri:level="1"><nlm:affiliation>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia, Spain. puig_joa@gva.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name>
<affiliation wicri:level="1"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region</wicri:regionArea>
<wicri:noRegion>Special Administrative Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name>
<affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kyncl, Jan" sort="Kyncl, Jan" uniqKey="Kyncl J" first="Jan" last="Kyncl">Jan Kyncl</name>
<affiliation wicri:level="3"><nlm:affiliation>National Institute of Public Health (NIPH), Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>National Institute of Public Health (NIPH), Prague</wicri:regionArea>
<placeName><settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name>
<affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, Saint Petersburg, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>Research Institute of Influenza, Saint Petersburg, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">BMC public health</title>
<idno type="eISSN">1471-2458</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Brazil (epidemiology)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>China (epidemiology)</term>
<term>Czech Republic (epidemiology)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Infant, Newborn (MeSH)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Population Surveillance (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Russia (epidemiology)</term>
<term>Seasons (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Turkey (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Brésil (épidémiologie)</term>
<term>Chine (épidémiologie)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Nouveau-né (MeSH)</term>
<term>Russie (épidémiologie)</term>
<term>République tchèque (épidémiologie)</term>
<term>Saisons (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Turquie (épidémiologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Brazil</term>
<term>China</term>
<term>Czech Republic</term>
<term>Influenza, Human</term>
<term>Russia</term>
<term>Spain</term>
<term>Turkey</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Brésil</term>
<term>Chine</term>
<term>Espagne</term>
<term>Grippe humaine</term>
<term>Russie</term>
<term>République tchèque</term>
<term>Turquie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Population Surveillance</term>
<term>Prospective Studies</term>
<term>Seasons</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Surveillance de la population</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Global Influenza Hospital Surveillance Network (GIHSN) has established a prospective, active surveillance, hospital-based epidemiological study to collect epidemiological and virological data for the Northern and Southern Hemispheres over several consecutive seasons. It focuses exclusively on severe cases of influenza requiring hospitalization. A standard protocol is shared between sites allowing comparison and pooling of results. During the 2014-2015 influenza season, the GIHSN included seven coordinating sites from six countries (St. Petersburg and Moscow, Russian Federation; Prague, Czech Republic; Istanbul, Turkey; Beijing, China; Valencia, Spain; and Rio de Janeiro, Brazil). Here, we present the detailed epidemiological and influenza vaccine effectiveness findings for the Northern Hemisphere 2014-2015 influenza season.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27556802</PMID>
<DateCompleted><Year>2017</Year>
<Month>08</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16 Suppl 1</Volume>
<PubDate><Year>2016</Year>
<Month>08</Month>
<Day>22</Day>
</PubDate>
</JournalIssue>
<Title>BMC public health</Title>
<ISOAbbreviation>BMC Public Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.</ArticleTitle>
<Pagination><MedlinePgn>757</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-016-3378-1</ELocationID>
<Abstract><AbstractText>The Global Influenza Hospital Surveillance Network (GIHSN) has established a prospective, active surveillance, hospital-based epidemiological study to collect epidemiological and virological data for the Northern and Southern Hemispheres over several consecutive seasons. It focuses exclusively on severe cases of influenza requiring hospitalization. A standard protocol is shared between sites allowing comparison and pooling of results. During the 2014-2015 influenza season, the GIHSN included seven coordinating sites from six countries (St. Petersburg and Moscow, Russian Federation; Prague, Czech Republic; Istanbul, Turkey; Beijing, China; Valencia, Spain; and Rio de Janeiro, Brazil). Here, we present the detailed epidemiological and influenza vaccine effectiveness findings for the Northern Hemisphere 2014-2015 influenza season.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puig-Barberà</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia, Spain. puig_joa@gva.es.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Burtseva</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yu</LastName>
<ForeName>Hongjie</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cowling</LastName>
<ForeName>Benjamin J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo><Affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Badur</LastName>
<ForeName>Selim</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kyncl</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>National Institute of Public Health (NIPH), Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sominina</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Research Institute of Influenza, Saint Petersburg, Russian Federation, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>GIHSN</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>08</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMC Public Health</MedlineTA>
<NlmUniqueID>100968562</NlmUniqueID>
<ISSNLinking>1471-2458</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N">Brazil</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018153" MajorTopicYN="N">Czech Republic</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012426" MajorTopicYN="N">Russia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N">Turkey</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Epidemiological study</Keyword>
<Keyword MajorTopicYN="Y">Hospitalization</Keyword>
<Keyword MajorTopicYN="Y">Influenza</Keyword>
<Keyword MajorTopicYN="Y">Surveillance</Keyword>
<Keyword MajorTopicYN="Y">Vaccine</Keyword>
<Keyword MajorTopicYN="Y">Virus</Keyword>
</KeywordList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Afanasieva</LastName>
<ForeName>Olga</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Afanasieva</LastName>
<ForeName>Veronica</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ciblak</LastName>
<ForeName>MeralAkcay</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aktas</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Badur</LastName>
<ForeName>Selim</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Belenguer-Varea</LastName>
<ForeName>Ángel</ForeName>
<Initials>Á</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Borekci</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Boza</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bursteva</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Buzitskaya</LastName>
<ForeName>Zhanna</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Caetano</LastName>
<ForeName>Braulia</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cai</LastName>
<ForeName>Jian</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Çakir</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carballido-Fernández</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carbonell-Franco</LastName>
<ForeName>Empar</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carratalá-Munuera</LastName>
<ForeName>Concha</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Çelebi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chai</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>de Paula</LastName>
<ForeName>IvamaraChangas de Lima Porto</ForeName>
<Initials>Ide L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Enfu</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cowling</LastName>
<ForeName>Ben</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cui</LastName>
<ForeName>Yunjie</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Deniz</LastName>
<ForeName>D B</ForeName>
<Initials>DB</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dondurei</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dong</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dong</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Durusu</LastName>
<ForeName>Mine</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>El Guerche-Séblain</LastName>
<ForeName>Clotilde</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Enda-Moura</LastName>
<ForeName>Fernanda</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Eren-Şensoy</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fadeev</LastName>
<ForeName>Artem</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Feng</LastName>
<ForeName>Luzhao</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Feng</LastName>
<ForeName>Shuo</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>César</LastName>
<ForeName>Raimundo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fisch</LastName>
<ForeName>Patricia</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Garina</LastName>
<ForeName>Ekaterina</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gencer</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gil-Guillén</LastName>
<ForeName>Vicente</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Go</LastName>
<ForeName>Alexa</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gonchar</LastName>
<ForeName>Vitaly</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Golovacheva</LastName>
<ForeName>Ekaterina</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Grudinin</LastName>
<ForeName>Mikhail</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hacımustafaoğlu</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hancerli</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Havlickova</LastName>
<ForeName>Martina</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Herrmannova</LastName>
<ForeName>Kristyna</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Huang</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jiang</LastName>
<ForeName>Hui</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ip</LastName>
<ForeName>Dennis</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jirincova</LastName>
<ForeName>Helena</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jurzykowska</LastName>
<ForeName>Lucie</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kisteneva</LastName>
<ForeName>Lidiya</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kolobukhina</LastName>
<ForeName>Ludmila</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Komissarov</LastName>
<ForeName>Andrey</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kralova</LastName>
<ForeName>Radka</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Krasnoslobotsev</LastName>
<ForeName>Kirill</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kyncl</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Labrador</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Li</LastName>
<ForeName>Chao</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Li</LastName>
<ForeName>Xiangxin</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Limón-Ramírez</LastName>
<ForeName>Ramón</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Jianhua</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carmen</LastName>
<ForeName>Mari</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mahé</LastName>
<ForeName>Cédric</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mandakova</LastName>
<ForeName>Zdenka</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Merkulova</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mese</LastName>
<ForeName>Sevim</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Iglesias</LastName>
<ForeName>AinaraMira</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mukasheva</LastName>
<ForeName>Evgenia</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sancho</LastName>
<ForeName>AngelsNatividad</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nováková</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Obraztsova</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Osidak</LastName>
<ForeName>Ludmila</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Del Carmen</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Özer</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ozisik</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Picot</LastName>
<ForeName>Valentina</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pisarev</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pradel</LastName>
<ForeName>Florence</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Prochazkova</LastName>
<ForeName>Jitka</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Puig-Barberá</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Qin</LastName>
<ForeName>Ying</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Raboni</LastName>
<ForeName>Sonia</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Roháčová</LastName>
<ForeName>Hana</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rozhkova</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Li</LastName>
<ForeName>Sa</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sadikhova</LastName>
<ForeName>M I</ForeName>
<Initials>MI</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schwarz-Chavarri</LastName>
<ForeName>Germán</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Siqueira</LastName>
<ForeName>Marilda</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Smorodintseva</LastName>
<ForeName>Elizaveta</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sominina</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stolyarov</LastName>
<ForeName>Kirill</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sukhovetskaya</LastName>
<ForeName>Vera</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sun</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tang</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tortajada-Girbés</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Trushakova</LastName>
<ForeName>Svetlana</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tuells</LastName>
<ForeName>José</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tumina</LastName>
<ForeName>Tatiana</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vartanyan</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Voloshuk</LastName>
<ForeName>Lubov</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Quanyi</ForeName>
<Initials>Q</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wen</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wu</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Xiao</LastName>
<ForeName>Wen</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yanina</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yi</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yu</LastName>
<ForeName>Hongjie</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yurtcu</LastName>
<ForeName>Kubra</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zarishnyuk</LastName>
<ForeName>Pavel</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Tiebiano</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zheng</LastName>
<ForeName>Jiandong</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Peng</LastName>
<ForeName>Zhibin</ForeName>
<Initials>Z</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>8</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27556802</ArticleId>
<ArticleId IdType="doi">10.1186/s12889-016-3378-1</ArticleId>
<ArticleId IdType="pii">10.1186/s12889-016-3378-1</ArticleId>
<ArticleId IdType="pmc">PMC5001209</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Euro Surveill. 2015 Feb 26;20(8):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25742432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2015 Jan 29;20(4):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25655053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14001-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10570188</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care Med. 2014 Nov;42(11):2325-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25148596</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. 2015 Mar 13;90(11):97-108</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25771542</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2013 Mar;56(5):677-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23074315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2016 May 19;11(5):e0154970</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27196667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2013 Oct 15;208(8):1305-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23863950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Sep 13;31(40):4280-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23850417</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. 2015 Jun 5;90(23):281-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26050269</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2015 Jul 21;:null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26198771</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Jun 19;9(6):e100497</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24945510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2011 Jun 15;203(12):1739-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21606532</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016;21(4):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26848118</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2015 May 15;211(10):1519-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25416812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2015 Aug 15;182(4):294-301</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26188191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Public Health. 2014 Jun 05;14:564</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24903737</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23210147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2013 Sep 15;188(6):710-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23855650</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Jun 26;31(30):3104-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23624093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2011 Jul;8(7):e1001053</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21750667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2016 Mar 8;34(11):1350-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26854911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25590680</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2014 Jun;2(6):445-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24717637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 Jul 15;59(2):166-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24785230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2010 Sep 15;202(6):881-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20677944</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2015 Feb 23;10(2):e0117716</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25706880</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2009 Aug;15(8):1271-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19751590</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
<li>Russie</li>
<li>République populaire de Chine</li>
<li>République tchèque</li>
<li>Turquie</li>
</country>
<region><li>Bohême centrale</li>
</region>
<settlement><li>Prague</li>
<li>Pékin</li>
</settlement>
</list>
<tree><country name="Espagne"><noRegion><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
</noRegion>
</country>
<country name="Russie"><noRegion><name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name>
</noRegion>
<name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name>
</country>
<country name="République populaire de Chine"><noRegion><name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name>
</noRegion>
<name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
</country>
<country name="Turquie"><noRegion><name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name>
</noRegion>
</country>
<country name="République tchèque"><region name="Bohême centrale"><name sortKey="Kyncl, Jan" sort="Kyncl, Jan" uniqKey="Kyncl J" first="Jan" last="Kyncl">Jan Kyncl</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000138 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000138 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeEspagneV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:27556802 |texte= Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27556802" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeEspagneV1
This area was generated with Dilib version V0.6.37. |